Archive for the ‘Arthritis’ Category
Saturday, June 7th, 2008
Research by academics at the University of Southampton in collaboration with occupational therapy clinicians into the effectiveness of wearing a particular type of silver ring to alleviate symptoms of arthritis has won an award.The research, which was carried out by academics from the University's School of Health Professions and Rehabilitation ...
Posted in Arthritis | No Comments »
Thursday, May 29th, 2008
HUMIRA (adalimumab) has been recommended by The National Institute for Health and Clinical Excellence (NICE) as one of the treatment options for adults with severe active ankylosing spondylitis (AS).[i] This is the first time that NICE has reviewed anti-TNF (anti-tumour necrosis factor) therapies for AS. Today's decision is also ...
Posted in Arthritis | No Comments »
Thursday, May 29th, 2008
The Arthritis Foundation applauds 274 members of Congress for co-sponsoring the Arthritis Prevention, Control, and Cure Act, S. 626/H.R. 1283. As of today, 53 senators and 221 representatives have shown leadership by co-sponsoring this landmark legislation. The bill, written and sponsored by Rep. Anna G. Eshoo (D-CA), will help combat ...
Posted in Arthritis | No Comments »
Thursday, May 15th, 2008
A common, incurable joint disease, osteoarthritis (OA) is the leading cause of disability in elderly people. While nearly any joint can be affected, OA most often strikes the knee, particularly the inner aspect of the tibiofemoral joint. One source of stress on this vulnerable joint compartment is the knee adduction ...
Posted in Arthritis | No Comments »
Thursday, May 15th, 2008
Roche Diagnostics announced the launch of a fully-automated immunoassay for the determination of autoantibodies to cyclic citrullinated peptides (Anti-CCP). The assay has been CE approved for use on the Elecsys / cobas e electrochemiluminescence immunoassay systems. The results of the Anti-CCP assay are intended to be used as an ...
Posted in Arthritis | No Comments »
Thursday, May 15th, 2008
Tick bites generate fears of Lyme disease in every parent, but this study of 99 children finds that one of Lyme's complications -- arthritis -- has a good prognosis. Researchers led by Robert Sundel, MD, a rheumatologist at Children's, found that 77 percent of children were cured with less than ...
Posted in Arthritis | No Comments »
Thursday, May 15th, 2008
The failure of the UK National Institute for Clinical Excellence (NICE) to approve treatment of the rheumatoid arthritis (RA) drug abatacept on the National Health Service (NHS) is discussed in the lead Editorial in this week's Lancet. Abatacept, is, with rituximab and tocilizumab, one of three new drug classes that ...
Posted in Arthritis | No Comments »
Thursday, April 10th, 2008
Nearly 60,000 women aged 55 years and older have enrolled in a landmark, multi-national study that will focus on the management of osteoporosis across the globe. Launch of the Global Longitudinal Registry of Osteoporosis in Women (GLOW) was announced at ECCEO 8 (Eighth European Congress on Clinical and Economic Aspects ...
Posted in Arthritis | No Comments »
Tuesday, April 8th, 2008
Time to take your life back - that's Arthritis Care's message to 7.8 million* people in the UK who live with chronic day-to-day pain. The 61-year old charity today marks its awareness week (12th-18th April) by launching its new Challenging Pain programme across the country.. Around half of those living ...
Posted in Arthritis | No Comments »
Tuesday, April 8th, 2008
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on inhibiting/slowing the progression of structural damage and reducing the signs and symptoms of rheumatoid arthritis during the first year of treatment are the attributes that ...
Posted in Arthritis | No Comments »
Tuesday, March 25th, 2008
The European Medicines Agency (EMEA) has been formally notified byNeurochem Luxco II SARL of its decision to withdraw the application fora centralised marketing authorisation for the medicine Kiacta(eprodisate disodium) capsules.Kiacta was expected to be used for the treatment of amyloid Aamyloidosis, a rare, life-threatening disease that occurs in patientswith long-lasting ...
Posted in Arthritis | No Comments »
Thursday, March 20th, 2008
Patients with rheumatoid arthritis treated with ACTEMRA™ (tocilizumab) experienced a rapid and significant reduction in the signs and symptoms of their disease, according to a study published in this week's issue of The Lancet. Results from the OPTION (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial a ...
Posted in Arthritis | No Comments »
Wednesday, March 19th, 2008
In a recent issue of The Johns Hopkins Arthritis Bulletin, Johns Hopkins specialists reported on the latest research regarding the link between rheumatoid arthritis and heart health. With rheumatoid arthritis, the inflammation that damages joints also takes a toll on the heart. Johns Hopkins specialists offer bottom line advice on ...
Posted in Arthritis | No Comments »
Monday, March 17th, 2008
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced that the regulatory authorities in the Netherlands have approved the clinical trial application (CTA) to initiate a phase 1 study of the HuCAL-derived antibody MOR103. MorphoSys had submitted the clinical trial application in December 2007. In parallel, MorphoSys has received ...
Posted in Arthritis | No Comments »
Tuesday, March 4th, 2008
A potential diagnostic test that could help surgeons confirm or rule out the presence of infection-causing bacteria in prosthetic joints that require surgical revision has been developed by researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH). ...
Posted in Arthritis | No Comments »